Development of liquid chromatography mass spectrometric methods for quantification of metabolites from cellular level to clinical biomarkers

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-04-24

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroendocrine Tumor Biomarkers: Current Status and Perspectives

  2014cited by this paper
• Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

  2014cited by this paper
• Do not just do it, do it right: urinary metabolomics--establishing clinically relevant baselines.

  2014cited by this paper
• Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.

  2014cited by this paper
• Analysis of oxysterols and vitamin D metabolites in mouse brain and cell line samples by ultra-high-performance liquid chromatography-atmospheric pressure photoionization-mass spectrometry.

  2014cited by this paper
• Comparison of two automated solid phase extractions for the detection of ten fentanyl analogs and metabolites in human urine using liquid chromatography tandem mass spectrometry.

  2014cited by this paper
• Long‐term evaluation of analytical methods used in sirolimus therapeutic drug monitoring

  2014cited by this paper
• Comparison of Arkray/ELITech ADAMS HA‐8180V® with Bio‐Rad Variant,TMII Turbo2.0® and Tosoh Bioscience HLC®‐723G8 for HbA1c Determination

  2014cited by this paper
• Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites.

  2013cited by this paper
• ‘Sweet Dreams’, ‘Happy Days’ and elevated 24-h urine 5-hydroxyindoleacetic acid excretion

  2013cited by this paper
• A Single Fasting Plasma 5-HIAA Value Correlates With 24-Hour Urinary 5-HIAA Values and Other Biomarkers in Midgut Neuroendocrine Tumors (NETs)

  2013cited by this paper
• Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.

  2013cited by this paper
• Isotopic abundance yields bias in the assessment of testosterone in a new reference method procedure.

  2013cited by this paper
• Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism.

  2013cited by this paper
• CE‐MS for metabolomics: Developments and applications in the period 2010–2012

  2013cited by this paper
• Solid-phase extraction based on hydrophilic interaction liquid chromatography with acetone as eluent for eliminating matrix effects in the analysis of biological fluids by LC-MS

  2013cited by this paper
• Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum.

  2013cited by this paper
• Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples.

  2013cited by this paper
• Interchangeability between 24‐hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma

  2013cited by this paper
• Glycolic acid production in the engineered yeasts Saccharomyces cerevisiae and Kluyveromyces lactis

  2013cited by this paper
• Ionic cross talk can lead to overestimation of 3-methoxytyramine during quantification of metanephrines by mass spectrometry.

  2012cited by this paper
• Development and optimization of simplified LC-MS/MS quantification of 25-hydroxyvitamin D using protein precipitation combined with on-line solid phase extraction (SPE).

  2012cited by this paper
• State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods.

  2012cited by this paper
• Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center

  2012cited by this paper
• Limitations of Chromogranin A in clinical practice

  2012cited by this paper
• The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory.

  2012cited by this paper
• Metabolite identification and quantitation in LC-MS/MS-based metabolomics.

  2012cited by this paper
• Standardized LC-MS/MS based steroid hormone profile-analysis.

  2012cited by this paper
• Sensitive, rapid and easy analysis of three catecholamine metabolites in human urine and serum by liquid chromatography tandem mass spectrometry.

  2012cited by this paper
• Binding of hepcidin to plasma proteins.

  2012cited by this paper
• LC-MS/MS in the Clinical Laboratory - Where to From Here?

  2011cited by this paper
• The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review.

  2011cited by this paper
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

  2011cited by this paper
• The epidemiology of gastroenteropancreatic neuroendocrine tumors.

  2011cited by this paper
• Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.

  2011cited by this paper
• Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods.

  2011cited by this paper
• Mass Spectrometry Strategies in Metabolomics*

  2011cited by this paper
• Current status and future developments of LC-MS/MS in clinical chemistry for quantification of biogenic amines.

  2011cited by this paper
• Microextraction by packed sorbent (MEPS): a tutorial.

  2011cited by this paper
• Principles of Electrospray Ionization

  2011cited by this paper
• Serum TSH reference interval in healthy Finnish adults using the Abbott Architect 2000i Analyzer

  2011cited by this paper
• A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma[S]

  2011cited by this paper
• Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting.

  2011cited by this paper
• Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results.

  2011cited by this paper
• High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory.

  2010cited by this paper
• Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours

  2010cited by this paper
• The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems

  2010cited by this paper
• GC/MS-based metabolomics reveals fatty acid biosynthesis and cholesterol metabolism in cell lines infected with influenza A virus.

  2010cited by this paper
• Quantitation of 25-OH-vitamin D (25OHD) using liquid tandem mass spectrometry (LC-MS-MS).

  2010cited by this paper
• Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory.

  2010cited by this paper
• AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development

  2010cited by this paper
• Measurement of plasma 5-hydroxyindole acetic acid by liquid chromatography tandem mass spectrometry--comparison with HPLC methodology.

  2010cited by this paper
• Coupling liquid chromatography to Orbitrap mass spectrometry.

  2010cited by this paper
• Effect of atenolol on aldosterone/renin ratio calculated by both plasma renin activity and direct renin concentration in healthy male volunteers

  2010cited by this paper
• NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor

  2010cited by this paper
• Global metabolic profiling procedures for urine using UPLC–MS

  2010cited by this paper
• Early Detection of Recurrent Breast Cancer Using Metabolite Profiling

  2010cited by this paper
• Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry.

  2010cited by this paper
• Metabolomics: Moving to the Clinic

  2010cited by this paper
• A rapid, simple and sensitive liquid chromatography-tandem mass spectrometry method for routine clinical monitoring of tacrolimus with the Waters Masstrak™ immmunosuppressant kit.

  2010cited by this paper
• Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.

  2009cited by this paper
• Challenges and developments in tandem mass spectrometry based clinical metabolomics.

  2009cited by this paper
• Determination of basic drugs of abuse in human serum by online extraction and LC–MS/MS

  2009cited by this paper
• Reference intervals for urinary catecholamines and metabolites from birth to adulthood.

  2009cited by this paper
• ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers

  2009cited by this paper
• Comparison of three immunoassays for CA 19-9.

  2009cited by this paper
• ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Follow-Up and Documentation

  2009cited by this paper
• Fast analysis of catecholamine metabolites MHPG and VMA in human plasma by HPLC with fluorescence detection and a novel SPE procedure.

  2009cited by this paper
• Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry.

  2009cited by this paper
• Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors

  2009cited by this paper
• Mass Spectrometry, Review of the Basics: Electrospray, MALDI, and Commonly Used Mass Analyzers

  2009cited by this paper
• The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men.

  2009cited by this paper
• Systems biology: Metabonomics

  2008cited by this paper
• Neuroendocrine tumor epidemiology

  2008cited by this paper
• Determination of the lipophilic antipsychotic drug ziprasidone in rat plasma and brain tissue using liquid chromatography-tandem mass spectrometry.

  2008cited by this paper
• Selected reaction monitoring for quantitative proteomics: a tutorial

  2008cited by this paper
• One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

  2008cited by this paper
• Development of sensitive derivatization method for aldosterone in liquid chromatography-electrospray ionization tandem mass spectrometry of corticosteroids.

  2008cited by this paper
• Overcoming matrix effects in liquid chromatography-mass spectrometry.

  2008cited by this paper
• Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors

  2008cited by this paper
• Rapid and Sensitive Method for Determination of Cyclophosphamide in Patients Plasma Samples Utilizing Microextraction by Packed Sorbent Online with Liquid Chromatography‐Tandem Mass Spectrometry (MEPS‐LC‐MS/MS)

  2008cited by this paper
• Matrix effect in liquid chromatography-electrospray ionization mass spectrometry analysis of benzoxazinoid derivatives in plant material.

  2007cited by this paper
• Capillary hydrophilic interaction chromatography/mass spectrometry for simultaneous determination of multiple neurotransmitters in primate cerebral cortex.

  2007cited by this paper
• Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.

  2007cited by this paper
• Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses.

  2007cited by this paper
• A Three-Decade Analysis of 3,911 Small Intestinal Neuroendocrine Tumors: The Rapid Pace of No Progress

  2007cited by this paper
• Anaerobic fermentation of glycerol: a path to economic viability for the biofuels industry.

  2007cited by this paper
• Biochemistry of neuroendocrine tumours

  2007cited by this paper
• Biochemistry of neuroendocrine tumours.

  2007cited by this paper
• Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma.

  2007cited by this paper
• Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry.

  2006cited by this paper
• Recent advances in methods for the analysis of catecholamines and their metabolites

  2006cited by this paper
• Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours

  2006cited by this paper
• Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: Examining lipid matrix ionization effects in plasma.

  2006cited by this paper
• Protein biomarker discovery and validation: the long and uncertain path to clinical utility

  2006cited by this paper
• Determination of M+4 stable isotope labeled cortisone and cortisol in human plasma by microElution solid-phase extraction and liquid chromatography/tandem mass spectrometry.

  2006cited by this paper
• Mass Spectrometry and Protein Analysis

  2006cited by this paper
• Neuroendocrine tumours (carcinoids) of the appendix.

  2005cited by this paper
• Application of the standard addition approach for the quantification of urinary benzene.

  2005cited by this paper
• Retention behavior of small polar compounds on polar stationary phases in hydrophilic interaction chromatography.

  2005cited by this paper

• No citing papers are available for this paper.